Lv71
4120 积分 2024-02-27 加入
Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China
2天前
已完结
The mutation spectrum of the JK‐null phenotype in the Chinese population
3天前
已完结
Red blood cell genotyping in China
3天前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
[Chinese expert consensus on the analytical validation of tumor comprehensive genomic profiling next generation sequencing testing (2024 edition)]
1个月前
已完结
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
1个月前
已关闭
MRD Assessment in Multiple Myeloma: Progress and Challenges
2个月前
已完结
The Diagnostic Utility of TRBC1 Immunohistochemistry in Mature T-Cell Lymphomas
2个月前
已完结
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
3个月前
已完结
皖公网安备34019202002308
